The “Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) “ report has been added to Research and Markets’ offering.
The global market is projected to display a robust growth represented by a CAGR of 22.67% during 2017-2022, chiefly driven by rising prevalence of obesity, diabetes and hypertension, rising clinical trials in Asian countries, heavy investments by government of different countries in their health care sector, rising research in developing the different health care machines and methodology for the detection of alcohol and non-alcohol steatosis at its early stage.
Over the recent years, the global fatty liver disease incidence has been growing rapidly with increase in prevalence of obesity, type II diabetes along with rising consumption of alcohol. Globally, the growth in the fatty liver disease market is driven by rising awareness among people by government organizations and private companies, heavy investments by pharmaceutical companies for the development of drugs along with launch of drugs for NASH in the forecasted period.
Companies Mentioned
– Allergan
– Astra Zenca
– Conatus
– Gilead Sciences
– Immuron
– Intercept Pharmaceuticals
– Novartis
– Pfizer
– Takeda
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
4. Fatty Liver Market Outlook
5. Global Fatty Liver Disease Market: Growth and Forecast
6. Global Fatty Liver Disease – Analysis By Type
7. Global Alcoholic Fatty Liver Disease Market – Analysis By Stages
8. Global Non Alcoholic Fatty Liver Disease Market- Analysis By Stages
9. Global Alcoholic Fatty Liver Disease Market – Analysis By Drugs
10. Global Non Alcoholic Fatty Liver Disease Market -By Drugs
11. Global Fatty Liver Disease Market – Pipeline Analysis (By developer, Phase and indication)
12. Global Fatty Liver Disease Market – Regional Analysis
13. North America Fatty liver Disease Market- An Analysis
14. North America Fatty Liver Disease Market -By Country Analysis
15. Asia Pacific Fatty liver Disease Market – An Analysis
16. Asia Pacific Fatty Liver Disease Market – By Country Analysis
17. Europe Pacific Fatty liver Disease Market- An Analysis
18. Europe Fatty Liver Disease Market – By Country Analysis
19. Rest of World Fatty liver Disease Market- An Analysis
20. Rest of World Fatty Liver Disease Market – By Country Analysis
21. Market Dynamics
22. Market Trends
23. Policy and Regulations
24. Porter Five Force
25. SWOT Analysis
26. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/bgh6gr/global_fatty